Skip to main content
Clinical Trials/ISRCTN13689468
ISRCTN13689468
Completed
未知

Development and implementation of a mindfulness-based intervention (REMIND2.0) for people in recovery in Hong Kong: the exploratory pilot randomised controlled trial

Hong Kong Baptist University0 sites28 target enrollmentJuly 19, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Facilitation of personal recovery among people with mental illness
Sponsor
Hong Kong Baptist University
Enrollment
28
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2022
End Date
January 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18 years or above
  • 2\. Permanent Hong Kong residents
  • 3\. Diagnosed with mental illness with standardised diagnostic criteria, such as the Classification of Diseases (11th ed.; ICD\-11; World Health Organization, 2018\) or Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM\-5; American Psychiatric Association, 2013\), for any length of illness
  • 4\. Capable of providing informed consent to participate in the trial; (v) able to understand Chinese languages to engage in the intervention or to complete written assessment in Chinese; and
  • 5\. A service user from the community\-based mental health service

Exclusion Criteria

  • 1\. Established diagnosis of learning disability or major cognitive impairment arising from any underlying medical condition resulting in significant functional impairment
  • 2\. Primary diagnosis of substance abuse, as substance use may increase and/or trigger symptoms of mental illnesses, and hence it has different trajectories from other mental illnesses
  • 3\. Mental state that precludes the possibility of engaging in the intervention (e.g. significant thought disorder)
  • 4\. Engagement in concurrent mindfulness intervention
  • 5\. Do not provide informed consent
  • 6\. Refused to be randomised

Outcomes

Primary Outcomes

Not specified

Similar Trials